Peste Des Petits Ruminants in Pakistan: Current Status, Challenges and Prospects for Vaccine Development
Vaccines · 28.10.2025 · 13 (11) · 1101
DOI: 10.3390/vaccines13111101 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 28.10.2025. Verfasst von Abdul Kabir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Microbiology, Faculty of Animal Husbandry and Veterinary Sciences, Sindh Agriculture University, Tando Jam 70060, Pakistan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Peste des petits ruminants (PPR) is a highly contagious viral disease that affects goats and sheep, causing severe clinical signs, high mortality, and significant economic losses in many developing countries. Pakistan is one of the endemic regions where PPR outbreaks caused by the Asian lineage IV virus have been reported frequently, affecting the livelihoods of millions of smallholder farmers who depend on these animals for food security and income generation. In this review, we provide a comprehensive overview of the current status, challenges and prospects for vaccine development against PPR in Pakistan. We discuss the epidemiology, diagnosis, and control of PPR in Pakistan, as well as the existing vaccines based on the attenuated strains and their limitations, such as low thermostability, short shelf life, and inability to differentiate between infected and vaccinated animals. We also highlight the recent advances in vaccine research and development, such as recombinant and vectored vaccines, thermostable formulations, and novel delivery methods that could overcome these limitations and enhance the immunogenicity and safety of PPR vaccines. We review the current and potential strategies for vaccine deployment, such as mass vaccination, targeted vaccination, ring vaccination, and their implications for the global eradication of PPR by 2030. We conclude by providing some recommendations for future research and development to improve vaccine efficacy, safety, and coverage in Pakistan, as well as to monitor the impact of vaccination on PPR incidence and prevalence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Microbiology, Faculty of Animal Husbandry and Veterinary Sciences, Sindh Agriculture University, Tando Jam 70060, Pakistan.
- National Veterinary Laboratory, Park Road, Islamabad 45500, Pakistan.
- Department of Veterinary Medicine, Faculty of Animal Husbandry and Veterinary Sciences, Sindh Agriculture University, Tando Jam 70060, Pakistan.
- Department of Microbiology, Faculty of Veterinary and Animal Sciences, The Islamic University of Bahawalpur, Bahawalpur 63100, Pakistan.
- Department of Pharmacology, Section Clinical Pharmacy, Shantou University Medical College, Shantou 515041, China.
- Intensive Care Unit, First Affiliated Hospital of Shantou University Medical College, Shantou 515041, China.
ORCID-Profile: Asghar Ali Kamboh, Muhammad Abubakar, Muhammad Tayyab Jabbar, Muhammad Shafiq
Zitieren
APA
Kabir, A., Kamboh, A. A., Abubakar, M., Rahman, A. U., Jabbar, M. T., Shafiq, M., & Lin, M. (2025). Peste Des Petits Ruminants in Pakistan: Current Status, Challenges and Prospects for Vaccine Development. Vaccines, 13(11), 1101. https://doi.org/10.3390/vaccines13111101
Vancouver
Kabir A, Kamboh AA, Abubakar M, Rahman AU, Jabbar MT, Shafiq M, et al. Peste Des Petits Ruminants in Pakistan: Current Status, Challenges and Prospects for Vaccine Development. Vaccines. 2025;13(11):1101. doi:10.3390/vaccines13111101
BibTeX
@article{Kabir2025,
author = {Kabir, Abdul and Kamboh, Asghar Ali and Abubakar, Muhammad and Rahman, Aness Ur and Jabbar, Muhammad Tayyab and Shafiq, Muhammad and Lin, Meirui},
title = {Peste Des Petits Ruminants in Pakistan: Current Status, Challenges and Prospects for Vaccine Development},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {11},
pages = {1101},
doi = {10.3390/vaccines13111101}
}
EUVIMED